Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus [ISRCTN70703138]

BMC Endocrine Disorders

Volumn 3, Issue , 2003, Pages

  Linn, Thomas ^a   Mann, Marion ^a   Mann, Markus ^a   Bretzel, Reinhard G ^a   Boedeker, Rolf H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; FOLLOW UP; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; PANCREAS ISLET CELL; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 2442654055     PISSN: 14726823     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6823-3-5     Document Type: Article

References (25)

1. Green A, Sjolie AK, Eshoj O: The epidemiology of diabetes mellitus. Insulin-dependent diabetes mellitus. From Textbook of Diabetes Volume Chapter 3. Edited by: Pickup JC, Williams G. Blackwell Science Ltd., Oxford; 1997:3.1-3.16.
2. The Diabetes Control and Complications Trial Study Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-989.
3. Schiffrin A, Suissa S, Weitzner G et al.: Factors predicting course of B-cell function in IDDM. Diabetes Care 1992, 15:997-1001.
4. Forst Th, Kunt Th, Pohlmann Th, Goitom K, Engelbach M, Beyer J, Pfuetzner A: Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1998, 101:2036-2041.
5. The Diabetes Control and Complications Trial Study Group: Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. Ann Intern Med 1998, 128:517-23.
6. Muehlhauser I, Overmann H, Bender R, Bott U, Berger M: Risk factors of severe hypoglycemia in adult patients with type 1 diabetes - a prospective population based study. Diabetologia 1998, 41:1274-1282.
7. Muller UA, Femerling M, Reinauer KM, Risse A, Voss M, Jorgens V, Berger M, Muhlhauser I: Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care 1999, 22(Suppl 2):B29-34.
8. Linn Th, Ortac K, Laube H, Federlin K: Intensive therapy in adult insulin dependent diabetes mellitus is associated with improved insulin sensitivity and reserve. A randomized, controlled, prospective study over five years in newly diagnosed patients. Metabolism 1996, 45:1508-1513.
9. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993, 329:977-986.
10. Schmidli RS, DeAizpurua HJ, Harrison LC, Colman PG: Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. J Autoimmun 1994, 7:55-66.
11. Montana E, Fernandez-Castaner M, Rosel P, Gomez J, Soler J: Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus. Diabetes-Metab 1991, 17:460-8.
12. Mühlhauser I, Sulzer M, Berger M: Quality assessment of diabetes care according to the recommendations of the St Vincent declaration: a population based study in a rural area of Austria. Diabetologia 1992, 36:429-435.
13. Liniger C, Albeanu A, Bloise D, Assal JP: The tuning fork revisited. Diabetic Medicine 1990, 7:859-864.
14. Kroll P: Augenfachärztlicher Untersuchungsbogen zur Früherkennung diabetischer Augenerkrankungen. Der Augenarzt 1993, 27:19-28.
15. Hesse L, Grüer M, Hoffstadt K, Jörgens V, Hartmann P, Kroll P: Populationsbezogene Erhebung zur diabetischen Retinopathie in Wolfsburg. Ophthalmologe 2001, 98:1065-1068.
16. Cole RA, Soeldner JS, Dunn PJ, Bunn HF: A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. Metabolism 1978, 27:289-301.
17. Sprangers MAG, Aaronson NK: The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. a review. J Clin Epidemiol 1992, 45:743-60.
18. Diabetes und Psychologie, Diagnostische Ansätze. Hrsg.: Carl-Walter Kohlmann und Bernd Kulzer. Verlag Hans Huber, Bern 1995.
19. Zelen M: A New Design for Randomized Clinical Trials,. New England Journal of Medicine 1979, 300:1242-1245.
20. Roth R, Kulzer B, Teupe B, Borkenstein M: Das Wissen von Typ-I-Diabetikern und Eltern diabetischer Kinder über die Krankheit Diabetes und deren Behandlung. Diabetes und Stoffwechsel 1993, 2:3-8.
21. Roth R, Kulzer B, Teupe B, Borkenstein M: Behandlungswissen und Behandlungsgewonheiten von Typ-I-Diabetikern in Relation zur Schulungsfähigkeit. Verhaltenstherapie 1993, 3(Suppl 1):A41.
22. Padget D, Mumford E, Hynes MCR: Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus. J Clinical Epidemiol 1988, 41:1007-1030.
23. Lewis KS, Bradley C, Knight G, Boulton AJ, Ward JD: A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet Med 1988, 5:235-42.
24. Herschbach P, Duran G, Waadt S, Zettler A, Amm C, Marten-Mittag B: Psychometric properties of the questionnaire on stress in patients with diabetes. Health Psychol 1997, 16:171-174.
25. European Diabetes Policy Group: A desktop guide to type-1 (insulin dependent) diabetes mellitus. Guidelines for diabetes care. Brussels, Belgium, Int. Diab. Federation, European Region 1998.